← FDA Drug Approvals (Drugs@FDA)

ROPIVACAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2020-04-09

Drug application

FDA Application #
ANDA212808
Application type
Abbreviated New Drug Application (Generic)
Brand name
ROPIVACAINE HYDROCHLORIDE
Generic name
ROPIVACAINE HYDROCHLORIDE
Active ingredients
ROPIVACAINE HYDROCHLORIDE
Dosage form
SOLUTION
Route
INJECTION
Marketing status
Prescription
Sponsor
CAPLIN
Manufacturer
Caplin Steriles Limited
First approval
2020-04-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown